Literature DB >> 21030112

Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005.

T L Lamagni1, N Potz, D Powell, R Pebody, J Wilson, G Duckworth.   

Abstract

A population-based study was undertaken to determine the short term risk of death in English patients diagnosed with meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia. All patients with an MRSA-positive blood culture taken in 2004 and 2005 in England identified through routine surveillance were matched to the national registry of deaths. The study found an overall case fatality (all-cause) within 7 days of MRSA-positive blood culture diagnosis of 20%, rising to 38% within 30 days. Risk of death was highest on the day subsequent to the blood specimen being drawn (4%). Seven-day case fatality rates in women were 16% higher than for men (odds ratio: 1.16; 95% confidence interval: 1.04-1.29), although no significant difference was discernable by day 30. Risk of death increased with rising age, with 28% (425/1513) of patients aged ≥85 years dying within 7 days and 57% (859/1513) within 30 days. A seasonal pattern in case fatality rates was evident, highest in the winter and lowest in the summer. The age-standardised mortality ratios within the first week were 180 and 225 times as high for men and women, respectively, as for the general population. This declined rapidly after 10 weeks to approximately 9 for both sexes. An estimated 5.53 deaths per 100,000 population followed MRSA bacteraemia in 2004 and 2005, although no inference on causality or attributable mortality could be made through this study. The stable, elevated risk of death observable after 10 weeks compared with that in the general population gave an indication of the background risk of death unrelated to MRSA infection.
Copyright © 2010 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21030112     DOI: 10.1016/j.jhin.2010.07.015

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  16 in total

1.  Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study.

Authors:  E Forsblom; A Kakriainen; E Ruotsalainen; A Järvinen
Journal:  Infection       Date:  2018-09-07       Impact factor: 3.553

2.  Risk factors for long-term mortality of Staphylococcus aureus bacteremia.

Authors:  D Yahav; S Yassin; H Shaked; E Goldberg; J Bishara; M Paul; L Leibovici
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

3.  Innate Sex Bias of Staphylococcus aureus Skin Infection Is Driven by α-Hemolysin.

Authors:  Moriah J Castleman; Srijana Pokhrel; Kathleen D Triplett; Donna F Kusewitt; Bradley O Elmore; Jason A Joyner; Jon K Femling; Geetanjali Sharma; Helen J Hathaway; Eric R Prossnitz; Pamela R Hall
Journal:  J Immunol       Date:  2017-12-08       Impact factor: 5.422

Review 4.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia.

Authors:  Emi Minejima; Joyce Bensman; Rosemary C She; Wendy J Mack; Martin Tuan Tran; Pamela Ny; Mimi Lou; Jason Yamaki; Paul Nieberg; Joyce Ho; Annie Wong-Beringer
Journal:  Crit Care Med       Date:  2016-04       Impact factor: 7.598

6.  Risk-adjusted monitoring of blood-stream infection in paediatric intensive care: a data linkage study.

Authors:  Katie Harron; Angie Wade; Berit Muller-Pebody; Harvey Goldstein; Roger Parslow; Jim Gray; John C Hartley; Quen Mok; Ruth Gilbert
Journal:  Intensive Care Med       Date:  2013-02-12       Impact factor: 17.440

7.  Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients.

Authors:  Guillermo Cuervo; Mariana Camoez; Evelyn Shaw; María Ángeles Dominguez; Oriol Gasch; Belén Padilla; Vicente Pintado; Benito Almirante; José Molina; Francisco López-Medrano; Enrique Ruiz de Gopegui; José A Martinez; Elena Bereciartua; Fernando Rodriguez-Lopez; Carlos Fernandez-Mazarrasa; Miguel Ángel Goenaga; Natividad Benito; Jesús Rodriguez-Baño; Elena Espejo; Miquel Pujol
Journal:  BMC Infect Dis       Date:  2015-10-30       Impact factor: 3.090

8.  Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.

Authors:  Mesut Yilmaz; Nazif Elaldi; İlker İnanç Balkan; Ferhat Arslan; Ayşe Alga Batırel; Mustafa Zahir Bakıcı; Mustafa Gokhan Gozel; Sevil Alkan; Aygül Doğan Çelik; Meltem Arzu Yetkin; Hürrem Bodur; Melda Sınırtaş; Halis Akalın; Fatma Aybala Altay; İrfan Şencan; Emel Azak; Sibel Gündeş; Bahadır Ceylan; Recep Öztürk; Hakan Leblebicioglu; Haluk Vahaboglu; Ali Mert
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-02-09       Impact factor: 3.944

9.  PEGylated Oligothioetheramide Prodrugs Activated by Host Serum Proteases.

Authors:  Christine M Artim; Manisha Kunala; Meghan K O'Leary; Christopher A Alabi
Journal:  Chembiochem       Date:  2021-07-13       Impact factor: 3.461

10.  Utility and limitations of Spa-typing in understanding the epidemiology of Staphylococcus aureus bacteraemia isolates in a single University Hospital.

Authors:  Giovanni Satta; Clare Louise Ling; Emma Shelley Cunningham; Timothy Daniel McHugh; Susan Hopkins
Journal:  BMC Res Notes       Date:  2013-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.